{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:45:40Z","timestamp":1795110340421,"version":"4.10.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7930","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Most current therapies that target plasma membrane receptors function by antagonizing ligand binding or enzymatic activities. However, typical mammalian proteins comprise multiple domains that execute discrete but coordinated activities. Thus, inhibition of one domain often incompletely suppresses the function of a protein. Indeed, targeted protein degradation technologies, including proteolysis-targeting chimeras\n                    <jats:sup>1<\/jats:sup>\n                    (PROTACs), have highlighted clinically important advantages of target degradation over inhibition\n                    <jats:sup>2<\/jats:sup>\n                    . However, the generation of heterobifunctional compounds binding to two targets with high affinity is complex, particularly when oral bioavailability is required\n                    <jats:sup>3<\/jats:sup>\n                    . Here we describe the development of proteolysis-targeting antibodies (PROTABs) that tether cell-surface E3 ubiquitin ligases to transmembrane proteins, resulting in target degradation both in vitro and in vivo. Focusing on zinc- and ring finger 3 (ZNRF3), a Wnt-responsive ligase, we show that this approach can enable colorectal cancer-specific degradation. Notably, by examining a matrix of additional cell-surface E3 ubiquitin ligases and transmembrane receptors, we demonstrate that this technology is amendable for \u2018on-demand\u2019 degradation. Furthermore, we offer insights on the ground rules governing target degradation by engineering optimized antibody formats. In summary, this work describes a strategy for the rapid development of potent, bioavailable and tissue-selective degraders of cell-surface proteins.\n                  <\/jats:p>","DOI":"10.1038\/s41586-022-05235-6","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:09:29Z","timestamp":1663762169000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":286,"title":["Antibody targeting of E3 ubiquitin ligases for receptor degradation"],"prefix":"10.1038","volume":"610","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-2765","authenticated-orcid":false,"given":"Hadir","family":"Marei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4800-8848","authenticated-orcid":false,"given":"Wen-Ting K.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Seir","family":"Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Penikalapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Saenz-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Dorighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-2564","authenticated-orcid":false,"given":"Yvonne T.","family":"Kschonsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelyn","family":"Kljavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhara","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3177-889X","authenticated-orcid":false,"given":"Eric","family":"Janezic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Heinlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Biehs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lehoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1728-9771","authenticated-orcid":false,"given":"Seth","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Comps-Agrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaya","family":"Seshasayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-2584","authenticated-orcid":false,"given":"Frederic J.","family":"de Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Grimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-2484","authenticated-orcid":false,"given":"Nicholas J.","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9558-3098","authenticated-orcid":false,"given":"Felipe","family":"de Sousa e Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"5235_CR1","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","volume":"98","author":"KM Sakamoto","year":"2001","unstructured":"Sakamoto, K. M. et al. Protacs: chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation. Proc. Natl Acad. Sci. USA 98, 8554\u20138559 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5235_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer 21, 638\u2013654 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"5235_CR3","doi-asserted-by":"publisher","first-page":"11615","DOI":"10.1021\/acs.jmedchem.0c00793","volume":"63","author":"L Goracci","year":"2020","unstructured":"Goracci, L. et al. Understanding the metabolism of proteolysis targeting chimeras (PROTACs): the next step towards pharmaceutical applications. J. Med. Chem. 63, 11615\u201311638 (2020).","journal-title":"J. Med. Chem."},{"key":"5235_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson, D. P. et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat. Chem. Biol. 11, 611\u2013617 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"5235_CR5","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aab1433","volume":"348","author":"GE Winter","year":"2015","unstructured":"Winter, G. E. et al. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 348, 1376\u20131381 (2015).","journal-title":"Science"},{"key":"5235_CR6","doi-asserted-by":"publisher","first-page":"10606","DOI":"10.1021\/acs.jmedchem.1c00895","volume":"64","author":"G Dong","year":"2021","unstructured":"Dong, G., Ding, Y., He, S. & Sheng, C. Molecular glues for targeted protein degradation: from serendipity to rational discovery. J. Med. Chem. 64, 10606\u201310620 (2021).","journal-title":"J. Med. Chem."},{"key":"5235_CR7","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1021\/acs.jmedchem.7b00237","volume":"60","author":"P Matsson","year":"2017","unstructured":"Matsson, P. & Kihlberg, J. How big is too big for cell permeability? J. Med. Chem. 60, 1662\u20131664 (2017).","journal-title":"J. Med. Chem."},{"key":"5235_CR8","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.cell.2017.10.033","volume":"171","author":"D Clift","year":"2017","unstructured":"Clift, D. et al. A method for the acute and rapid degradation of endogenous proteins. Cell 171, 1692\u20131706.e1618 (2017).","journal-title":"Cell"},{"key":"5235_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41594-021-00560-2","volume":"28","author":"J Zeng","year":"2021","unstructured":"Zeng, J. et al. Target-induced clustering activates trim-away of pathogens and proteins. Nat. Struct. Mol. Biol. 28, 278\u2013289 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"5235_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik, S. M. et al. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature 584, 291\u2013297 (2020).","journal-title":"Nature"},{"key":"5235_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao, H. X. et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485, 195\u2013200 (2012).","journal-title":"Nature"},{"key":"5235_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nature11308","volume":"488","author":"BK Koo","year":"2012","unstructured":"Koo, B. K. et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488, 665\u2013669 (2012).","journal-title":"Nature"},{"key":"5235_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759\u2013767 (1990).","journal-title":"Cell"},{"key":"5235_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"F de Sousa e Melo","year":"2017","unstructured":"de Sousa e Melo, F. et al. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature 543, 676\u2013680 (2017).","journal-title":"Nature"},{"key":"5235_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/978-1-0716-0747-3_23","volume":"2171","author":"EMF de Sousa","year":"2020","unstructured":"de Sousa, E. M. F. et al. Modeling colorectal cancer progression through orthotopic implantation of organoids. Methods Mol. Biol. 2171, 331\u2013346 (2020).","journal-title":"Methods Mol. Biol."},{"key":"5235_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fphar.2013.00030","volume":"4","author":"A Arcaro","year":"2013","unstructured":"Arcaro, A. Targeting the insulin-like growth factor-1 receptor in human cancer. Front. Pharmacol. 4, 30 (2013).","journal-title":"Front. Pharmacol."},{"key":"5235_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.annonc.2019.09.004","volume":"31","author":"M Kundranda","year":"2020","unstructured":"Kundranda, M. et al. Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE). Ann. Oncol. 31, 79\u201387 (2020).","journal-title":"Ann. Oncol."},{"key":"5235_CR18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/cam4.263","volume":"3","author":"EH Lin","year":"2014","unstructured":"Lin, E. H. et al. A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer. Cancer Med. 3, 988\u2013997 (2014).","journal-title":"Cancer Med."},{"key":"5235_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/protein\/9.7.617","volume":"9","author":"JB Ridgway","year":"1996","unstructured":"Ridgway, J. B., Presta, L. G. & Carter, P. 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 9, 617\u2013621 (1996).","journal-title":"Protein Eng."},{"key":"5235_CR20","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s00216-019-01735-z","volume":"411","author":"N Nupur","year":"2019","unstructured":"Nupur, N. & Rathore, A. S. Usability of NISTmAb reference material for biosimilar analytical development. Anal. Bioanal. Chem. 411, 2867\u20132883 (2019).","journal-title":"Anal. Bioanal. Chem."},{"key":"5235_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1021\/acschembio.5b00753","volume":"11","author":"AS Dixon","year":"2016","unstructured":"Dixon, A. S. et al. NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem. Biol. 11, 400\u2013408 (2016).","journal-title":"ACS Chem. Biol."},{"key":"5235_CR22","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1073\/pnas.1431613100","volume":"100","author":"L Girnita","year":"2003","unstructured":"Girnita, L., Girnita, A. & Larsson, O. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc. Natl Acad. Sci. USA 100, 8247\u20138252 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5235_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.chembiol.2021.04.007","volume":"28","author":"A Kannt","year":"2021","unstructured":"Kannt, A. & Dikic, I. Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation. Cell. Chem. Biol 28, 1014\u20131031 (2021).","journal-title":"Cell. Chem. Biol"},{"key":"5235_CR24","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1634\/theoncologist.2018-0785","volume":"24","author":"A Sartore-Bianchi","year":"2019","unstructured":"Sartore-Bianchi, A. et al. HER2 positivity predicts unresponsiveness to EGFR-targeted treatment in metastatic colorectal cancer. Oncologist 24, 1395\u20131402 (2019).","journal-title":"Oncologist"},{"key":"5235_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/jacs.0c10008","volume":"143","author":"AD Cotton","year":"2021","unstructured":"Cotton, A. D., Nguyen, D. P., Gramespacher, J. A., Seiple, I. B. & Wells, J. A. Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1. J. Am. Chem. Soc. 143, 593\u2013598 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"5235_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature14397","volume":"520","author":"M Yu","year":"2015","unstructured":"Yu, M. et al. A resource for cell line authentication, annotation and quality control. Nature 520, 307\u2013311 (2015).","journal-title":"Nature"},{"key":"5235_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"5235_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11295","volume":"7","author":"K Srinivasan","year":"2016","unstructured":"Srinivasan, K. et al. Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses. Nat. Commun. 7, 11295 (2016).","journal-title":"Nat. Commun."},{"key":"5235_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1158\/1535-7163.MCT-17-0657","volume":"17","author":"D Mandikian","year":"2018","unstructured":"Mandikian, D. et al. Relative target affinities of T-cell-dependent bispecific antibodies determine biodistribution in a solid tumor mouse model. Mol. Cancer Ther. 17, 776\u2013785 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"5235_CR30","doi-asserted-by":"publisher","first-page":"1600319","DOI":"10.1002\/pmic.201600319","volume":"17","author":"JA Paulo","year":"2017","unstructured":"Paulo, J. A. & Gygi, S. P. Nicotine-induced protein expression profiling reveals mutually altered proteins across four human cell lines. Proteomics 17, 1600319 (2017).","journal-title":"Proteomics"},{"key":"5235_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pmic.201200439","volume":"13","author":"JK Eng","year":"2013","unstructured":"Eng, J. K., Jahan, T. A. & Hoopmann, M. R. Comet: an open-source MS\/MS sequence database search tool. Proteomics 13, 22\u201324 (2013).","journal-title":"Proteomics"},{"key":"5235_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nmeth1019","volume":"4","author":"JE Elias","year":"2007","unstructured":"Elias, J. E. & Gygi, S. P. Target\u2013decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207\u2013214 (2007).","journal-title":"Nat. Methods"},{"key":"5235_CR33","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.cell.2010.12.001","volume":"143","author":"EL Huttlin","year":"2010","unstructured":"Huttlin, E. L. et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174\u20131189 (2010).","journal-title":"Cell"},{"key":"5235_CR34","doi-asserted-by":"publisher","first-page":"ra25","DOI":"10.1126\/scisignal.2003572","volume":"6","author":"G Zhuang","year":"2013","unstructured":"Zhuang, G. et al. Phosphoproteomic analysis implicates the mTORC2\u2013FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases. Sci. Signal. 6, ra25 (2013).","journal-title":"Sci. Signal."},{"key":"5235_CR35","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1074\/mcp.RA120.002105","volume":"19","author":"T Huang","year":"2020","unstructured":"Huang, T. et al. MSstatsTMT: statistical detection of differentially abundant proteins in experiments with isobaric labeling and multiple mixtures. Mol. Cell. Proteomics 19, 1706\u20131723 (2020).","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05235-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05235-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05235-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T19:04:27Z","timestamp":1664996667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05235-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":35,"journal-issue":{"issue":"7930","published-print":{"date-parts":[[2022,10,6]]}},"alternative-id":["5235"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05235-6","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are current or former employees of Genentech.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}